Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferric Derisomaltose in Acute HFpEF with Iron Deficiency
NCT05991128Phase 4Unknown
- Sponsor
- China-Japan Friendship Hospital
- Start
- Aug 2023
- Primary completion
- Aug 2024
- Modality
- Inorganic Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in iron deficiency anemia (IDA) comparing Ferric derisomaltose with Placebo (2 arms). Primary endpoint: 6-minute walking distance at 3 days. Status: unknown.
02
Drugs
ferric derisomaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT05991128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05991128.